Tavs Qvist
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Lineages and adapted phenotypes of Pseudomonas aeruginosa persist during elexacaftor/tezacaftor/ivacaftor therapy.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: December 05, 2025
Elexacaftor/tezacaftor/ivacaftor is safe and effectively reduces sino-nasal symptoms in people with cystic fibrosis post lung transplantation.
Journal: Respiratory medicine
Published: October 30, 2025
Limitations of PICADAR as a diagnostic predictive tool for primary ciliary dyskinesia.
Journal: Frontiers in molecular biosciences
Published: August 24, 2025
Treatment outcomes of nontuberculous mycobacterial infection in the Danish Cystic Fibrosis Cohort 2012-23.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 28, 2025
Body mass, linear growth, and body composition before and after the introduction of elexacaftor/tezacaftor/ivacaftor among children and adults with cystic fibrosis.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: April 23, 2025
Water, Water Everywhere, Nor Any Drop to Drink: Beware of Mycobacteria.
Journal: American journal of respiratory and critical care medicine
Published: March 25, 2025
Change in pulmonary pathogens 3 years after elexacaftor/tezacaftor/ivacaftor: an observational study in the Danish cystic fibrosis cohort.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 31, 2025
Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: Impact on Hospitalizations and Health Care Resource Utilization in a Universal Health Care Setting.
Journal: Pulmonary therapy
Published: December 02, 2024
Real-World Improvements of Lung Clearance Index and Ventilation Distribution Efficiency in Children With Cystic Fibrosis After Elexacaftor/Tezacaftor/Ivacaftor Initiation.
Journal: Pediatric pulmonology
Published: November 20, 2024
First Case of Primary Ciliary Dyskinesia in Greenland.
Journal: Pediatric pulmonology
Published: November 11, 2024
Long-Term Lung Function and Pseudomonas aeruginosa Infection in Genotyped Primary Ciliary Dyskinesia.
Journal: Annals of the American Thoracic Society
Published: October 24, 2024
Last Updated: 09/26/2026